4,213
Views
18
CrossRef citations to date
0
Altmetric
Clinical Studies

Treatment of Proteinuria with Lercanidipine Associated with Renin-Angiotensin Axis-Blocking Drugs

, , , &
Pages 192-197 | Received 13 Sep 2009, Accepted 23 Nov 2009, Published online: 03 Mar 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Costas Tsioufis, Kyriakos Dimitriadis, Emmanouil Mantzouranis, Ilianna Mani & Dimitrios Tousoulis. (2016) Differential effects of lercanidipine/enalapril versus amlodipine/enalapril and hydrochlorothiazide/enalapril on target organ damage and sympathetic activation in non-obese essential hypertensive subjects. Current Medical Research and Opinion 32:sup2, pages 35-41.
Read now
Nicolas Roberto Robles, Carlos Calvo, Javier Sobrino, Eugenia Espinel, Rafael Esteban, Lourdes Mateos & Juan F Macias. (2016) Lercanidipine valuable effect on urine protein losses: the RED LEVEL study. Current Medical Research and Opinion 32:sup2, pages 29-34.
Read now
Michel Burnier. (2013) Renal protection with calcium antagonists: the role of lercanidipine. Current Medical Research and Opinion 29:12, pages 1727-1735.
Read now
Carlos Escobar, Rocio Echarri & Vivencio Barrios. (2012) Emerging drug combinations to optimize renovascular protection and blood pressure goals. International Journal of Nephrology and Renovascular Disease 5, pages 69-80.
Read now
Arrigo F. G. Cicero, Beatrice Gerocarni, Martina Rosticci & Claudio Borghi. (2012) Blood Pressure and Metabolic Effect of a Combination of Lercanidipine with Different Antihypertensive Drugs in Clinical Practice. Clinical and Experimental Hypertension 34:2, pages 113-117.
Read now

Articles from other publishers (13)

Marina G. Bubnova. (2022) Optimizing therapy for cardiovascular diseases: proven organ-protective and preventive effects of pitavastatin and lercanidipine: A review. CardioSomatics 13:1, pages 31-42.
Crossref
Divya Prabhu, Akshay Rao, Anjana Rajanna, Sakthi Kannan & Selva Kumar. (2022) Urinary Albumin to Creatinine Ratio to Predict Diabetic Retinopathy: The Eyes Have It!. Cureus.
Crossref
O. B. Kuzmin, V. V. Zhezha & V. V. Belyanin. (2021) Dihydropyridine calcium channel blockers for the renoprotective therapy of hypertensive patients with chronic kidney disease. Nephrology (Saint-Petersburg) 25:2, pages 27-34.
Crossref
Francesco Fici, Elif Ari Bakir, Elif Ilkay Yüce, Serdal Kanuncu, Wim Makel, Bahar Arican Tarim & Nicolás Roberto Robles. (2020) PAIT-Survey Follow-Up: Changes in Albuminuria in Hypertensive Diabetic Patients with Mild-Moderate Chronic Kidney Disease. High Blood Pressure & Cardiovascular Prevention 27:1, pages 43-49.
Crossref
Giuseppe Mancia & Kostantinos Tsioufis. (2019) Current perspective on the use of calcium channel blockers to treat hypertensive patients: the role of lercanidipine. Future Cardiology 15:4, pages 259-266.
Crossref
Sen Adachi, Shin-ichiro Miura, Yuhei Shiga, Tadaaki Arimura, Joji Morii, Takashi Kuwano, Ken Kitajima, Atsushi Iwata, Natsumi Morito, Kanta Fujimi, Eiji Yahiro, Hiroaki Nishikawa & Keijiro Saku. (2017) Effects of Tolvaptan With or Without the Pre-Administration of Renin-Angiotensin System Blockers in Hospitalized Patients With Acute Decompensated Heart Failure. International Heart Journal 58:3, pages 385-392.
Crossref
Nicolás R Robles, Francesco Fici & Guido Grassi. (2016) Dihydropyridine calcium channel blockers and renal disease. Hypertension Research 40:1, pages 21-28.
Crossref
G S Anikin. (2014) Pleiotropic features of dihydropyridine calcium channel antagonists. Systemic Hypertension 11:3, pages 81-83.
Crossref
L. O. Minushkina. (2013) COMBINATION THERAPY IN THE MANAGEMENT OF ARTERIAL HYPERTENSION: EFFECTIVENESS OF THE LERCANIDIPINE AND ENALAPRIL COMBINATION. Cardiovascular Therapy and Prevention 12:5, pages 75-80.
Crossref
Aleksandr Mikhaylovich Shilov. (2013) Blokatory kal'tsievykh kanalov III pokoleniya pri lechenii arterial'noy gipertonii. Systemic Hypertension 10:3, pages 38-43.
Crossref
A V Rodionov. (2013) Combined pharmacotherapy for arterial hypertension: a view through the 2013 clinical practice guidelines. Systemic Hypertension 10:2, pages 5-8.
Crossref
Nicolás R. Robles & Roman Hernandez-Gallego. (2012) Blood Pressure in Renal Disease: How to Accomplish the Goal?. Cardiovascular Therapeutics 30:4, pages 193-198.
Crossref
Arrigo F.G. Cicero, Beatrice Gerocarni, Martina Rosticci & Claudio Borgh. (2012) Blood Pressure and Metabolic Effect of a Combination of Lercanidipine with Different Antihypertensive Drugs in Clinical Practice. Cardiovascular Therapy and Prevention 11:1, pages 36-40.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.